PMID- 16498791 OWN - NLM STAT- MEDLINE DCOM- 20060316 LR - 20161018 IS - 1019-5297 (Print) IS - 1019-5297 (Linking) IP - 8 DP - 2005 Dec TI - [Effect of alpha-difluoromethylornithine and polyhexamethyleneguanidine (PMG), polyamine biosynthesis inhibitors on leucosis L1210 growth kinetics and life expectancy of animals with cancer]. PG - 76-81 AB - The article deals with the study of polyamines content and y-glutamiltranspeptidase (gamma-GTP) activity in leucosis L1210 cells under the influence of inhibitors of polyamines synthesis such as alpha-difluoromethylornithine (alpha-DFMO) and polyhexamethylenguanidine (PMG). Injections of alpha-DFMO and PMG to animals essentially reduce putrescine and spermidine concentrations, and the levels of spermine and gamma-GTP activity increase under this influence. These modulation were associated with L1210 leucosis growth retardation. Antiblastic effect was dependent on inhibitors' doses and mode of injections' course. Under the optimum conditions the retardation index was 90-98%. The animals with retarded tumor growth had essentially longer survival time frame than blank tumor-bearing animals (index was 37.2 for a-DFMO and 67.5 for PMG). FAU - Zaletok, S P AU - Zaletok SP FAU - Berdinskikh, N K AU - Berdinskikh NK FAU - Lialiushko, N M AU - Lialiushko NM FAU - Klenov, O A AU - Klenov OA FAU - Samoilenko, E A AU - Samoilenko EA FAU - Lidak, M Iu AU - Lidak MIu LA - rus PT - English Abstract PT - Journal Article PL - Ukraine TA - Lik Sprava JT - Likars'ka sprava JID - 9601540 RN - 0 (Antineoplastic Agents) RN - 0 (Biogenic Polyamines) RN - 0 (Guanidines) RN - 31961-54-3 (polyhexamethyleneguanidine) RN - ZQN1G5V6SR (Eflornithine) SB - IM MH - Animals MH - Antineoplastic Agents/pharmacology/*therapeutic use MH - Biogenic Polyamines/antagonists & inhibitors/*biosynthesis MH - Eflornithine/pharmacology/*therapeutic use MH - Guanidines/pharmacology/*therapeutic use MH - Kinetics MH - Leukemia L1210/*drug therapy/metabolism/pathology MH - Life Expectancy MH - Mice MH - Mice, Inbred Strains MH - Neoplasm Transplantation EDAT- 2006/02/28 09:00 MHDA- 2006/03/17 09:00 CRDT- 2006/02/28 09:00 PHST- 2006/02/28 09:00 [pubmed] PHST- 2006/03/17 09:00 [medline] PHST- 2006/02/28 09:00 [entrez] PST - ppublish SO - Lik Sprava. 2005 Dec;(8):76-81.